🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
The main purpose of this study is to collect additional safety information ...
Status
Completed
Location
Anhui Cancer Hospital
Start Date
2020-05-18
Trial ID
NCT04328662
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
Ixazomib combined with low-dose lenalidomide(10mg) vs Ixazomib alone as mai...
Status
Recruiting
Location
Yang Xu
Start Date
2022-07-01
Trial ID
NCT05722405
Treatments Being Tested
A Phase IB/II Trial of Lenalidomide (Revlimid®), Ixazomib and Rituximab (RI...
Status
Terminated
Location
University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-02-20
Trial ID
NCT02898259
Treatments Being Tested
The purpose of Phase 1 of this study was to determine the safety, tolerabil...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2010-11-22
Trial ID
NCT01217957
Treatments Being Tested
Open-label study to evaluate the safety and efficacy of Ixazomib in combina...
Status
Terminated
Location
University Hosptial Toulouse
Start Date
2016-08-05
Trial ID
NCT02897830
Treatments Being Tested